Stock ScreenerStock IdeasFounder-Led CompaniesFounder-Led CompaniesA Bain & Co. study found that founder-led companies performed "3.1 times better" during the study period of 1999 to 2014
Stock ScreenerStock IdeasFounder-Led Companies
Ticker: AIV + 109 more
| Ticker | Company | Zen Rating | Growth | Market Cap | Revenue | EBITDA | Earnings | EPS | Rev. Y/Y | Rev. 5Y | Earn. Y/Y | Earn. 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JAZZ | JAZZ PHARMACEUTICALS PLC | $10.28B | $4.16B | $182.64M | -$368.48M | -$5.99 | 4.14% | 12.77% | N/A | N/A | |||
| AIV | APARTMENT INVESTMENT & MANAGEMENT CO | $854.37M | $194.41M | $387.96M | $243.67M | $1.72 | 4.51% | N/A | N/A | N/A | 2026-02-24 | ||
| LPSN | LIVEPERSON INC | $36.16M | $257.66M | -$73.27M | -$133.26M | -$22.67 | -23.03% | -5.59% | N/A | N/A | 2026-02-19 | ||
| MPW | MEDICAL PROPERTIES TRUST INC | $3.13B | $933.52M | $81.19M | -$707.21M | -$1.18 | 45.56% | -4.45% | N/A | N/A | 2026-02-19 | ||
| ARE | ALEXANDRIA REAL ESTATE EQUITIES INC | $10.10B | $3.06B | $1.16B | -$421.07M | -$2.47 | -0.76% | 10.84% | N/A | N/A | 2026-01-26 | ||
| RARE | ULTRAGENYX PHARMACEUTICAL INC | $2.19B | $630.60M | -$541.42M | -$579.83M | -$5.93 | 20.63% | 24.00% | N/A | N/A | 2026-02-12 | ||
| HR | HEALTHCARE REALTY TRUST INC | $6.06B | $1.20B | $503.44M | -$367.31M | -$1.07 | -6.59% | 10.58% | N/A | N/A | 2026-03-04 | ||
| VSAT | VIASAT INC | $5.77B | $4.58B | $1.22B | -$522.34M | -$4.02 | 1.23% | 15.14% | N/A | N/A | 2026-02-10 | ||
| W | WAYFAIR INC | $14.39B | $12.24B | $105.00M | -$325.00M | -$2.57 | 3.35% | -1.21% | N/A | N/A | 2026-02-19 | ||
| BYND | BEYOND MEAT INC | $424.54M | $290.57M | -$193.13M | -$237.71M | -$3.16 | -10.17% | -6.35% | N/A | N/A | 2026-03-04 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.